Investment Trusts

Fidelity Emerging Markets Ltd

GG00B4L0PD47:GBX

Fidelity Emerging Markets Ltd

  • Price (GBX)657.50
  • Today's Change0.60 / 0.09%
  • Shares traded3.60k
  • 1 Year change12.89%
  • Beta0.7698
Data delayed at least 20 minutes, as of Apr 23 2024 12:36 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceFidelity Emerging Markets Ltd (Ordinary Share)+14.21%
NAVFidelity Emerging Markets Ltd (Ordinary Share)+10.02%
Morningstar's BenchmarkMSCI EM TR--

Key statistics

As of last trade Fidelity Emerging Markets Ltd (GG00B4L0PD47:GBX) traded at 657.50, -11.18% below its 52-week high of 740.30, set on Mar 26, 2024.
52-week range
Today
568.10Jul 10 2023740.30Mar 26 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding76.58m
Market cap496.69m GBP
Total assets562.79m GBP
Total expense ratio0.81%
High665.00
Low649.00
Previous close656.90
Average volume48.70k
YTD Change+6.72%
Beta0.7698
Diluted NAV (est)742.78
Diluted NAV (last pub)734.92
Premium/Discount-12.33%
Net Gearing0.00%
Annual div (ADY)15.31 GBX
Annual div yield (ADY)2.33%
Div ex-dateNov 16 2023
Div pay-dateDec 15 2023
Data delayed at least 20 minutes, as of Apr 23 2024 12:36 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.